| Open Price | 161.65 | Shares Traded | 1709 |
| High Price | 163.50 | 52 Wk High | 275.95 |
| Low Price | 161.65 | 52 Wk Low | 141.05 |
| Previous Close | 161.35 | Face Value | 10.00 |
| 52 Wk High Date | 28-07-2011 | 52 Wk Low Date | 22-12-2011 |
| Open Price | 162.00 | Shares Traded | 3460 |
| High Price | 165.00 | 52 Wk High | 276.00 |
| Low Price | 162.00 | 52 Wk Low | 149.00 |
| Previous Close | 162.35 | Face Value | 10.00 |
| 52 Wk High Date | 28-07-2011 | 52 Wk Low Date | 22-12-2011 |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| Year End | Mar, 2012 | Mar, 2012 | Mar, 2012 |
| Sales (Rs.cr) | 114.63 | 404.92 | 404.92 |
| Net Profit (Rs.cr) | 15.56 | 51.27 | 51.27 |
| Net Profit Var (%) | 15.00 | 8.00 | 8.00 |
| EPS (Rs) | - | 52.60 | |
| P/E Ratio | - | 3.10 | 3.10 |
| Operating Profit Margin | - | 22.10 | - |
| CPS (Rs.) | - | - | 63.00 |
| P/C Ratio | - | - | 2.60 |
| Div% | - | - | - |
| Related Companies | ||
| Stock Name | Price | |
| AMBASARABH | 3.82 | |
| AMRUTANJAN | 750.85 | |
| BLISSGVS | 21.15 | |
| GERMANREMEDIES | 473.20 | |
| MAKERSLABORATORIES | 18.00 | |
| RHONEPOULENCI | 363.30 | |
| TND | 53.00 | |
| PHAREASTLABS | 2.80 | |
| MJ | 5.25 | |
| TWILITAKA | 27.85 | |
| Fundamentals | |
| Market Capital (Rs.cr) | 160.56 |
| EPS (Rs.)(TTM) | |
| P/E Ratio(TTM) | 3.10 |
| Book Value (Rs.) | 304.10 |
| Price to Book Value | 0.54 |
| Equity (Rs.cr.) | 9.74 |
| Traded Value (Rs.lac) | 13.54 |
| Announcements | |
| 31-03-2011 | Venus Remedies allots equity shares |
| 22-12-2011 | Venus Remedies allots warrants |
| 23-05-2012 | Venus Remedies bags another patent grant from South Africa |
| 28-12-2010 | Venus remedies gets patent for sulbactomax from Russia & Ukraine |
| 15-11-2011 | Venus Remedies receives market authorisation for Meropenem in UK & New Zealand |
| 02-02-2011 | Venus Remedies receives UK MHRA approval For anti-Cancer drug Gemcitabine |
| 26-07-2011 | Venus Remedies recommends dividend |
| 28-02-2012 | Venus Remedies to allot equity shares |
| 17-08-2011 | Venus Remedies to allot shares & warrants |
| 19-07-2011 | Venus Remedies to consider dividend |
| 27-12-2010 | Venus Remedies to expand innovations basket with Sulbactomax Patent |
| 13-12-2011 | Venus Remedies to hold board meeting |
| 04-04-2011 | Venus Remedies wins QC-100 TQM Award in Gold Category from Geneva |
| 09-12-2010 | Venus successfully completed phase III clinical trials of new Aminoglycoside molecule |
| Gross Deliverables | |||||
| Date | Del. Shares | Trd. Qty. | Del.(%) | Del. Value | Turnover |
| 15-05-2012 | 3585 | 4825 | 74.30 | 592600 | 795.97 |
| 11-05-2012 | 3583 | 6224 | 57.57 | 610006 | 1,062.89 |
| 09-05-2012 | 3511 | 4972 | 70.62 | 588795 | 832.24 |
| 08-05-2012 | 5307 | 8069 | 65.77 | 885738 | 1,346.84 |
| 04-05-2012 | 6542 | 11370 | 57.54 | 1049010 | 1,840.31 |
